Request Info


Ask for our annual reports or more information
Email Us

Email Alerts

Sign up for email alerts
Email Alerts
Investor Relations

News Release

RSS RSS Feeds
Printer Friendly Version View printer-friendly version
<< Back
Meridian Bioscience Recognized as One of Forbes' 200 Best Growth Companies in America

CINCINNATI--(BUSINESS WIRE)--Oct. 15, 2003--Meridian Bioscience, Inc., Cincinnati, Ohio (Nasdaq:VIVO) today announced that Forbes has recognized it as one of the "200 Best Growth Companies in America", as reported in their October 27, 2003 edition.

The Forbes 200 Best Growth Companies in America list is selected from a database of 3,500 candidates whose last 12-month sales range between $5 million and $600 million. Additional qualification criteria included profitability tests and liquidity.

William J. Motto, Chairman and Chief Executive Officer, commented, "We are pleased to have been recognized by Forbes Magazine as one of the 200 Best Small Companies in America. This recognition is a tribute to the efforts of all Meridian Bioscience employees."

Meridian is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. Utilizing a variety of methods, these products provide accuracy, simplicity and speed in the early diagnosis and treatment of common medical conditions, such as gastrointestinal, viral, urinary and respiratory infections. All Meridian products are used outside of the human body and require little or no special equipment. The Company's products are designed to enhance patient well-being while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal and upper respiratory infections, serology, parasitology and fungal disease diagnosis. In addition, Meridian is a supplier of rare reagents and specialty biologicals. The Company markets its products to hospitals, reference laboratories, research centers, veterinary testing centers and physician offices in more than 60 countries around the world. The Company's shares are traded through Nasdaq's National Market, symbol VIVO. Meridian's website address is www.meridianbioscience.com.

CONTACT: Meridian Bioscience, Inc.
John A. Kraeutler, 513-271-3700

SOURCE: Meridian Bioscience, Inc.